<DOC>
	<DOC>NCT02358057</DOC>
	<brief_summary>The main objective is to determine if dexmedetomidine combine with alfentanil allow a level of conscious sedation within maximum security conditions in an emergency department. Patients included in the study will receive an injection of dexmedetomidine via a TIVA Injectomat Agilia, specially programmed for the injection of dexmedetomidine. Patients will also receive a dose of alfentanil, 1 minute before the technical act.</brief_summary>
	<brief_title>Can we Get Conscious Sedation by Combining Dexmedetomidine With Alfentanil?</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Alfentanil</mesh_term>
	<criteria>Adult over 18 years, of both sexes, for which a procedural sedation is needed in emergency room. The rules for sedation, in accordance with the international guidelines, are: The insertion of a chest drain Abscess incision and drainage Closed reduction of a dislocated joint Patients refusing to participate in the study (refusal to sign the consent form) Patients refusing sedation Patients unable to participate in the study (consent is impossible to obtain) Pregnant women The hypersensitivity to the active ingredient, dexmedetomidine hydrochloride. Patients with poor respiratory status determined by: Respiratory rate &gt; 30 / min Oxygen saturation &lt;90% Patients with unfavorable hemodynamic status determined by : A heart rate &gt; 120 / min A heart rate &lt; 50 / min Systolic blood pressure ≥ 180 mmHg or ≤100mmHg Diastolic blood pressure ≥ 110mmHg Patients with contraindication to the use of dexmedetomidine : Advanced heart block (level 2 or 3) unless pacemaker Acute cerebrovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Deep sedation</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Emergency Service, Hospital</keyword>
</DOC>